Skip to main content

Peer Review reports

From: A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury

Original Submission
29 Apr 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
15 Sep 2015 Editorially accepted
23 Sep 2015 Article published 10.1186/s12906-015-0861-7

You can find further information about peer review here.

Back to article page